检索结果 - Jonathan Golas

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)

    Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1) 由 Matthew Sung, Xingzhi Tan, Bingwen Lu, Jonathan Golas, Christine Hosselet, Fang Wang, Laurie Tylaska, Lindsay King, Dahui Zhou, Russell G. Dushin, Jeremy S. Myers, Edward Rosfjord, Judy Lucas, Hans‐Peter Gerber, Frank Loganzo

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models

    SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models 由 Jennifer M. Golas, Judy Lucas, Carlo Etienne, Jonathan Golas, Carolyn Discafani, Latha Sridharan, Erwin R. Boghaert, Kim Arndt, Fei Ye, Diane H. Boschelli, Fangbiao Li, Craig Titsch, Christine Huselton, Inder Chaudhary, Frank Boschelli

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors

    Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors 由 Changhua Ji, Marc D. Roy, Jonathan Golas, Allison Vitsky, Sripad Ram, Steven W. Kumpf, Matthew T. Martin, Frank Barletta, William A. Meier, Andrea T. Hooper, Puja Sapra, Nasir Khan, Martin B. Finkelstein, Magali Guffroy, Bernard S. Buetow

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

    Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase 由 Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord, Michelle Baxter, M. Brawner Floyd, Jonathan Golas, William Hallett, Bernard D. Johnson, Ramaswamy Nilakantan, Elsebe Overbeek, Marvin F. Reich, Ru Shen, Xiaoqing Shi, Hwei‐Ru Tsou, Yu‐Fen Wang, Allan Wissner

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma

    Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma 由 Pedro Molina-Sánchez, Marina Ruiz de Galarreta, Melissa A. Yao, Katherine E. Lindblad, Erin Bresnahan, Elizabeth Bitterman, Tiphaine Martin, Troy Rubenstein, Kai Nie, Jonathan Golas, Shambhunath Choudhary, Marina Bárcena‐Varela, Abdülkadir Elmas, Verónica Miguela, Ying Ding, Zhengyan Kan, Lauren Tal Grinspan, Kuan‐lin Huang, Ramon Parsons, David J. Shields, Robert A. Rollins, Amaia Lujambio

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

    A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers 由 Divya Mathur, Adam R. Root, Bozena Bugaj‐Gaweda, Stephanie Bisulco, Xingzhi Tan, Wei Fang, Jessica Kearney, Justin Lucas, Magali Guffroy, Jonathan Golas, Cynthia M. Rohde, Chad Stevens, Cris Kamperschroer, Kerry Kelleher, Rosemary F. Lawrence-Henderson, Erik Upeslacis, Johnny Yao, Jatin Narula, Edward R. LaVallie, Diane R. Fernandez, Bernard S. Buetow, Edward Rosfjord, Laird Bloom, Lindsay E. King, Lioudmila Tchistiakova, Anhco Nguyen, Puja Sapra

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: